"Silent" Diabetes and Clinical Outcome After Treatment With Contemporary Drug-Eluting Stents: The BIO-RESORT Silent Diabetes Study
Conclusions
Abnormal glucose metabolism was detected in 1 of 3 "nondiabetic" PCI patients and was independently associated with up to 4-fold higher event risks. Future intervention trials should determine whether meaningful benefits accrue from routine glycemia testing in such patients.
Source: Journal of the American College of Cardiology: Cardiovascular Interventions - Category: Cardiology Authors: von Birgelen, C., Kok, M. M., Sattar, N., Zocca, P., Doelman, C., Kant, G. D., Löwik, M. M., van der Heijden, L. C., Sen, H., van Houwelingen, K. G., Stoel, M. G., Louwerenburg, J. W., Hartmann, M., de Man, F. H. A. F., Linssen, G. C. M., Doggen, Tags: Coronary Source Type: research
More News: Angioplasty | Cardiology | Cardiovascular | Coronary Angioplasty | Diabetes | Endocrinology | Heart | Heart Attack | Percutaneous Coronary Intervention | Study